Axon Therapies Revenue and Competitors
Estimated Revenue & Valuation
- Axon Therapies's estimated annual revenue is currently $6M per year.
- Axon Therapies's estimated revenue per employee is $251,000
Employee Data
- Axon Therapies has 24 Employees.
- Axon Therapies grew their employee count by 4% last year.
Axon Therapies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Engineering/Ops | Reveal Email/Phone |
2 | Clinical Engineer | Reveal Email/Phone |
Axon Therapies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $160M | 800 | 4% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is Axon Therapies?
Axon Therapies is addressing a root cause of heart failure with their frontline therapy by selectively ablating the neural pathway carrying information from the chronically hyperactive sympathetic nervous system (SNS) in order to restore volume balance, stop disease progression and improve symptoms
keywords:N/A
N/A
Total Funding
24
Number of Employees
$6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Axon Therapies News
2022-04-17 - NeuraLace announces two new patents for Axon neuropathic pain ...
... non-pharmacological Axon therapy and advanced applications, such as robotics for applying Axon Therapy, including US Patent No.
2022-02-22 - Axon Therapies Appoints Industry Veteran Brian Farley to Board of ...
"The Axon Therapies' SAVM procedure is a highly promising approach that targets the body's overactive sympathetic nervous system, which is known...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 24 | -23% | N/A |
#2 | $3.8M | 24 | -8% | N/A |
#3 | $1.7M | 24 | -14% | $3.3M |
#4 | $2.4M | 24 | -20% | N/A |
#5 | $2.4M | 24 | N/A | N/A |